A new online service, dubbed TreatMyUTI.com, is offering patients what it says is the first online access to physician diagnosis and treatment of uncomplicated urinary tract infections with no office visit, exam or lab test required.
Craft brewers saw a 15% rise in volume and a 17% increase in dollar growth, the Brewers Association said today as they released preliminary 2012 data on U.S. craft brewing growth ahead of the Craft Brewers Conference to be held in Washington, D.C., March 26 to 29.
In the wake of a new partnership announcement between Walgreens and AmerisourceBergen, Cardinal Health announced on that its pharmaceutical distribution contract with Walgreens that is scheduled to expire at the end of August 2013 will not be renewed.
Cenoire, a manufacturer of portable electronic accessories, has announced the availability of its new electronic toothbrush, the Eluo Ultra. The Eluo Ultra is a dual frequency sonic toothbrush discretely disguised in a mascara compact case.
Patients with coronary artery disease who are adherent to their prescribed medications can save the healthcare system up to $868 per patient per year, according the findings of a recent study conducted by researchers at Brigham and Women’s Hospital and CVS Caremark.
The U.S. Government Accountability Office on Monday advised the Food and Drug Administration to establish a time frame on New Dietary Ingredient guidance, as well as guidance clarifying whether a liquid product may be labeled and marketed as a dietary supplement or as a conventional food with added ingredients.
A survey of 114 researchers, government officials, insurers, employers, business leaders and trade groups found nearly one-third say comparative effectiveness research will have a "moderate improvement" on healthcare decision making over the next 12 months.
The question of whether a generic drug company can be held liable for harmful side effects from its medicines goes before the Supreme Court Tuesday in a case involving a New Hampshire woman who sustained several injuries after taking a generic pain drug.
Even as Walgreens expands its operation globally through strategic partnerships with both Alliance Boots and now AmerisourceBergen, the pharmacy operator continues to create some retail pop in the U.S. market.
Walgreens will no longer source branded prescription medicines directly from suppliers beginning in September, the Chicago-based retailer announced as part of a significant partnership between Walgreens, Alliance Boots and AmerisourceBergen that includes Walgreens and Alliance Boots potentially taking a 7% stake in the Pennsylvania wholesaler.